top of page

WHAT DO WE DO?

Translational Research

We work collaboratively on basic research, proof-of-concept studies, and pre-IND studies to discover the biological mechanisms of drug addiction, develop novel small-molecule, biological, and device-based therapeutics approaches.

NEUROSCIENCE

Neuroanatomy
Cellular physiology
Functional Connectivity
Opto/chemogenetic 

We use basic and advanced neuroscience approaches to study the impact of drugs on the brain and the neuroadaptations responsible for addictive behaviors

MEDICATION DEVELOPMENT

Pre-IND, Proof-of-Concept, Pharmacokinetic, and Drug Screening Studies

We work with chemists in both academia and the pharmaceutical industry to test the efficacy of promising compounds in reversing the effects of drugs on the brain, reducing drug use, and preventing relapse in animal models.

BEHAVIORAL PHENOTYPING

State-of-the-Art Animal Models

We have one of the largest drug self-administration phenotyping program in the country, with the capability of testing over 150 animals simultaneously. We use state-of-the-art animal models, including chronic intravenous, oral, and vapor self-administration combined with advanced analyses of behavior responses despite increases in cost to obtain the drug or the presence of adverse consequences.

NOVEL THERAPEUTIC APPROACHES

Deep Brain Stimulation
Vaccines
Biologics

We are developing new therapeutics, including deep brain stimulation to reduce opioid use, vaccines to prevent opioid intoxication, and enzymatic approaches to prevent nicotine from reaching the brain.

freezer full of biological samples.jpg

A repository of biological specimens from behaviorally and genetically characterized rats

We provide comprehensive biological tissue banks based on outbred rats that have been characterized as vulnerable or resistant to cocaine or oxycodone addiction-like behaviors.

bottom of page